Eli Lilly And Co’s LLY much-in-demand weight-loss drug Zepbound (tirzepatide) surged ahead with 77,590 new prescriptions in the U.S. for the…

Read more

The recent expansion of Novo Nordisk A/S’s NVO Wegovy’s (semaglutide) FDA approval has sparked a debate over insurance coverage for the drug.  However,…

Read more

Amazon.com’s AMZN Amazon Pharmacy has integrated Eli Lilly And Co’s LLY LillyDirect into its services, enabling home delivery of select medications for diabetes, obesity,…

Read more

Novo Nordisk A/S NVO’s Wegovy garnered the Food and Drug Administration’s approval for expanded use Friday, marking what the drugmaker…

Read more

© Reuters. On Tuesday, Stephens, a financial services firm, adjusted its outlook on DermTech Inc. (NASDAQ:), reducing the stock price…

Read more

Viking Therapeutics Inc VKTX recently released top-line results from a successful Phase 2 weight loss trial. Patients receiving VK2735 demonstrated statistically…

Read more

Goldman Sachs economists foresee a potential 1% boost to the United States’ Gross Domestic Product (GDP) in the coming years, attributing…

Read more

© Reuters. On Wednesday, Wells Fargo adjusted its stance on Allegion (NYSE:), a company known for its security products and…

Read more

Preliminary findings presented at an orthopedic surgeons’ meeting on Monday indicate that new drugs designed for diabetes and weight loss…

Read more